期刊文献+

艾司洛尔在脓毒症中的作用研究进展 被引量:3

RESEARCH ADVANCES IN THE ROLE OF ESMOLOL IN SEPSIS
下载PDF
导出
摘要 脓毒症是重症医学领域的常见病、多发病。近年来的研究表明,艾司洛尔在脓毒症中发挥良好的作用,为脓毒症潜在的治疗药物。本文就艾司洛尔在心肌保护、抗炎、改善微循环、改善预后等方面的作用进行综述,阐述艾司洛尔在脓毒症中的作用。 Sepsis is a common and frequently occurring disease in the field of critical care medicine.Recent studies have shown that esmolol plays a good role in sepsis and is a potential treatment method for sepsis.This article reviews the role of esmolol in myocardial protection,anti-inflammation,and improvement of microcirculation and prognosis and elaborates on the role of esmolol in sepsis.
作者 白雪 王春朋 山峰 BAI Xue;WANG Chunpeng;SHAN Feng(Intensive Care Unit,The Affiliated Hospital of Qingdao University,Qingdao 266100,China)
出处 《青岛大学学报(医学版)》 2021年第4期629-632,共4页 Journal of Qingdao University(Medical Sciences)
基金 青岛市医药科研指导计划项目(2016-WJZD026)。
关键词 脓毒症 艾司洛尔 药物生理作用 综述 sepsis esmolol physiological effects of drugs review
  • 相关文献

参考文献10

二级参考文献116

  • 1郭继鸿.β受体阻滞剂应当成为快速心律失常治疗的基础用药[J].中国心脏起搏与心电生理杂志,2005,19(5):331-334. 被引量:80
  • 2游凯,严晓伟,任洪智,蒋豪,沈潞华,郭静萱,张京范,李志善,邵建华,张运,黄洁,陈珏,张秀华,徐建青,刘小颖,黄捷英,张福春,张兴华,吴明慧,李莉,杨芳.静脉艾司洛尔治疗快速性室上性心律失常临床疗效及安全性评价(309例多中心研究)[J].中华心血管病杂志,1996,24(6):404-407. 被引量:38
  • 3张萍.交感风暴[J].临床心电学杂志,2007,16(1):74-75. 被引量:52
  • 4Gaziano TA, Opie LH, Weinstein MC. Cardiovascular disease prevention with a muhidrug regimen in the developing world: a cost-effectiveness analysis[J]. Lancet, 2006,19,368(9536) :679
  • 5Lanza CA, Fox K, Crea F. Heart rate: a risk factor for cardiac diseases and outcomes? Pathophysiology of cardiac diseases and the potential role of heart rate slowing[ J ]. Adv Cardiol,2006,43:1
  • 6Siddiqui A, Kowey PR. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies[ J]. Curr Opin Cardiol,2006,21(5) :517
  • 7Viitasalo M, Oikarinen L, Swan H, et al. Effects of beta-blocker therapy on ventricular repolarization documented by 24 h electrocardiography in patients with type 1 long-QT syndrome[J]. J Am Coll Cardiol,2006,48 (4) :747
  • 8Pedersen ME, Cockcroft JR. The latest generation of beta-blockers :new pharmacologic properties [ J ]. Curr Hypertens Rep, 2006, 8(4):279
  • 9Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary : a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines[J]. Eur Heart J, 2006,27(16) :1 979
  • 10Zipes DP, Carom AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sadden cardiac death-executive summary : a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines [ J ]. Eur Heart J, 2006,27 ( 17 ) :2 099

共引文献189

同被引文献20

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部